Preeclampsia and aspirin
Preeclampsia (PE) is a multisystem disorder that is an important cause of maternal and perinatal deaths. Currently, delivery is the only final treatment for PE. This practice is usually accompanied by premature birth, which inevitably increases neonatal morbidities. Aspirin is a non-selective non-st...
Main Authors: | Tae Gyu Ahn, Jong Yun Hwang |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Society of Obstetrics and Gynecology
2023-05-01
|
Series: | Obstetrics & Gynecology Science |
Subjects: | |
Online Access: | http://ogscience.org/upload/pdf/ogs-22261.pdf |
Similar Items
-
Comparison of the efficacy of 75 mg aspirin versus 150 mg aspirin for prevention of preeclampsia in patients at high risk for preeclampsia
by: Dr. Natasha Bushra, et al.
Published: (2024-03-01) -
Association between Serum HLA-G Levels in The First Trimester of Pregnancy and The Onset of Preeclampsia: A Systematic Review and Meta-analysis Study
by: Salome Maghsudlu, et al.
Published: (2023-10-01) -
Low-Dose Aspirin after ASPRE—More Questions Than Answers? Current International Approach after PE Screening in the First Trimester
by: Piotr Tousty, et al.
Published: (2023-05-01) -
Predictive Performance of Machine Learning-Based Methods for the Prediction of Preeclampsia—A Prospective Study
by: Alina-Sinziana Melinte-Popescu, et al.
Published: (2023-01-01) -
Preventive effect of aspirin on preeclampsia in high‐risk pregnant women with stage 1 hypertension
by: Jing Huai, et al.
Published: (2021-05-01)